Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
Oluwatoyosi Adewunmi(Baylor College of Medicine), Jeffrey M. Rosen(Baylor College of Medicine)
Cited by 56
Related Papers
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
|Nature Communications|2021|59
The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states
|BMC Biology|2016|50
Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression
|Oncogene|2017|50
Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer
|Journal of Clinical Investigation|2023|29